Last $1.30 USD
Change Today -0.01 / -0.76%
Volume 89.7K
STEM On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 10:08 AM 09/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Martin M. McGlynn

Chief Executive Officer, President, Director, Member of Strategic Transactions Committee, Chief Executive Officer of StemCells California Inc and President of StemCells California Inc, StemCells Inc.
AgeTotal Calculated CompensationThis person is connected to 8 board members in 1 different organizations across 1 different industries.

See Board Relationships
68$2,118,094
As of Fiscal Year 2013

Background*

Mr. Martin M. McGlynn has been the Chief Executive Officer and President of Stemcells Inc. and of its wholly-owned subsidiary, StemCells California, Inc. since January 15, 2001. Mr. McGlynn joined Stemcells Inc. in January 15, 2001. He began his career with Becton Dickinson, Ireland Ltd., and spent 8 years in manufacturing operations. He has been Secretary of Alliance for Regenerative Medicine since January 2013. He joined Abbott Labs in 1977 where he served as General ...

Read Full Background

Corporate Headquarters*

7707 Gateway Boulevard
Newark, California 94560

United States

Phone: 510-456-4000
Fax: 510-456-4001

Board Members Memberships*

2001-Present
Chief Executive Officer, President, Director, Member of Strategic Transactions Committee, Chief Executive Officer of StemCells California Inc and President of StemCells California Inc

Education*

Bachelor's Degree 1968
University College Dublin

Other Affiliations*

Annual Compensation*

Salary$548,461
Bonus$287,375
Total Annual Compensation$835,836

Stock Options*

Restricted Stock Awards$1,239,000
All Other Compensation$43,258
Exercisable Options26,249
Unexercisable Options3,751
Total Number of Options30,000

Total Compensation*

Total Annual Cash Compensation$879,094
Total Short Term Compensation$835,836
Other Long Term Compensation$1,282,258
Total Calculated Compensation$2,118,094
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
STEM:US $1.31 USD -0.005

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Dominick C. Colangelo Esq.Chief Executive Officer, President, Treasurer and Director
Aastrom Biosciences, Inc.
$358.3K
Michael D. West Ph.D.Chief Executive Officer, President and Director
BioTime, Inc.
$745.3K
Andrey Semechkin Ph.D.Co-Chairman and Chief Executive Officer
International Stem Cell Corporation
$258.5K
Mark Weinreb M.S.Chairman, Chief Executive Officer, President, Principal Financial Officer and Principal Accounting Officer
BioRestorative Therapies, Inc.
$360.0K
Steven A. Victor M.D.Chairman, Chief Executive Officer, President, Principal Accounting Officer, Treasurer and Secretary
IntelliCell BioSciences, Inc.
$275.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact STEMCELLS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.